Center of Psychotherapy, Psychosomatics and Psychedelic Medicine Expio
Opening Hours : Mon-Fri 10.00 - 19.00.
Tel. +380 7373 080 88
According to the Centers for Disease Control and Prevention (CDC), depression alone causes 200 million lost work days each year, costing employers more than $44 billion.
Dr. Bonners, CEO of Magic Soap, saw the depth of mental health problems many workers faced during the pandemic, so he turned his attention to the drug ketamine, which is currently used to treat depression and anxiety.
At the beginning of June this year, the director of the Expio center, Vladyslav Matrenytskyi, took part in an international seminar on ketamine-assisted therapy in Barcelona (Spain), which was jointly organized by the "Sinaptica" clinic (Barcelona), the Dr. Scheib Institute (Mallorca) and the Ketamine Research Foundation (KRF). , USA).
During the comprehensive 5-day program, participants delved into the theory and practice of psychedelic ketamine therapy and gained the knowledge and skills necessary for confident independent use of these treatment methods.
During the seminar, Vladyslav Matrenytskyi spoke to the participants about the peculiarities of the use of ketamine therapy during the war in Ukraine.
TV channel Arte (Germany) made a report about the mental trauma of war and its overcoming, including with the help of psychedelic therapy in our clinic.
"After almost two years of war, Ukraine is a traumatized nation. A significant part of the population suffers from physical or psychological injuries, and often from both. Tracks East looks at how the country is dealing with mass trauma.”
https://www.arte.tv/en/videos/117217-003-A/tracks-east/
In an interview on the Kyiv TV channel, the director of the Expio center, V. L. Matrenytskyi, talks about the psychedelic therapy of civilians and soldiers who suffered during the war.
Psychedelics can help them overcome their trauma and possibly fight back
Ihor Kholodylo was probably not supposed to survive. A military psychologist and medic was evacuating his comrades in early 2023 when his jeep was hit by a Russian tank shell. He remained barely able to communicate. The operation saved his heart and eyesight. But doctors were unable to correct his speech problem and stuttering. He tried all kinds of radical therapy, but nothing helped. Then he met Vladyslav Matrenytskyi, a pioneer of psychedelic psychotherapy, who asked an unexpected question. Would he try ketamine?
Last week, Congress approved a defense spending bill that will fund military research and clinical trials of cannabis, psilocybin and other psychedelic drugs to determine their effectiveness in treating service members and veterans with post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Adoption of section 723 Law on Authorization for National Defense (NDAA) would allow members of the military to undergo psychedelic therapy and provide $10 million to explore this option as a new approach to mental health treatment.
Back in June, the Senate Appropriations Committee proposed military spending bill , which contains several requests for the 2024 military construction budget. Among these requests was an important directive to expand research into the therapeutic benefits of psychedelics. The committee urged the Department of Veterans Affairs (VA) to investigate the potential of these substances to treat various health conditions common among veterans, such as post-traumatic stress disorder, major depressive disorder, and chronic pain. This directive was a crucial component of a broader approach to treating veterans' mental health through psychedelic therapy.
In this issue, France24's "Reporter" program talks about the impact of the war on the mental health of the Ukrainian population, especially the military who are fighting at the front. The conflict is already leaving consequences such as post-traumatic stress and anxiety, and society is facing difficulties in dealing with these problems due to the Soviet legacy.
The program includes an interview with the director of the EXPIO center, V. L. Matrenytskyi.
In the video settings (gear), select Subtitulos – Traducion automatico – Ukrainano.
https://www.france24.com/es/programas/reporteros/20231212-guerra-en-ucrania-la-salud-mental-en-juego
Psilocybin, MDMA and LSD began to be used for the treatment of mental disorders in world therapy as early as the 70s of the last century. These substances are still prohibited in Ukraine. And for the treatment of depression, anxiety and post-traumatic stress disorder (PTSD), more traditional methods are used - psychotherapy and antidepressants.
Part of the people who do not manage to recover thanks to these methods could be helped by psychedelic-assisted therapy, which is currently little known in Ukraine. However, among psychedelic substances, only ketamine is currently approved for such treatment.
What is ketamine therapy and how to treat mental disorders with its help - in the hromadske material.
Photo: public TV
Silence that can cost a life!
The American Academy of Pediatrics estimates that 85 percent of women worldwide suffer from some type of postpartum mood disorder. Of these, 10-15% of women suffer from clinical postpartum depression and 0.1-0.2% from postpartum psychosis.
Unfortunately, there are no statistics on postpartum depression in Ukraine, but this does not mean that the problem does not exist. In addition, the war further increased the psychological and emotional stress of women in labor.
What is postpartum depression, how to recognize it?